THREE-YEAR OUTCOMES OF INTRAVITREAL AFLIBERCEPT INJECTION FOR TREATMENT NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

被引：0
|
作者：
Motoki, K. [1 ]
Yoshimi, N. [1 ]
Masayuki, O. [1 ]
Kyoko, F. [1 ]
Tomoyuki, C. [1 ]
Kazuki, N. [1 ]
Kanji, T. [1 ]
机构：
[1] Kansai Med Univ, Dept Ophthalmol, Osaka, Japan
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2017年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
PM-01
引用
收藏
页码：E81 / E82
页数：2
相关论文
共 50 条
  • [1] Three-year Outcomes of Treat and Extend Aflibercept Treatment for Neovascular Age-related Macular Degeneration
    Kataoka, Keiko
    Asai, Keiko
    Tsunekawa, Yuma
    Ito, Yasuki
    Terasaki, Hiroko
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [2] Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naive Patients with Neovascular Age-related Macular Degeneration
    Eleftheriadou, Maria
    Gemenetzi, Maria K.
    Sivaprasad, Sobha
    Hykin, Philip G.
    Hamilton, Robin
    Tufail, Adnan
    Patel, Praveen J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [3] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    [J]. DRUGS & AGING, 2012, 29 (10) : 839 - 846
  • [4] Three-year outcomes of a treat and extend regimen of aflibercept for neovascular age-related macular degeneration
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Shiode, Yusuke
    Hirano, Masayuki
    Doi, Shinichiro
    Toshima, Shinji
    Takahashi, Kosuke
    Fujiwara, Atsushi
    Kanzaki, Yuki
    Hosogi, Mika
    Shiraga, Fumio
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Ohr, Matthew
    Kaiser, Peter K.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (04) : 585 - 591
  • [6] Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
    Eleftheriadou, Maria
    Gemenetzi, Maria
    Lukic, Marko
    Sivaprasad, Sobha
    Hykin, Philip G.
    Hamilton, Robin D.
    Rajendram, Ranjan
    Tufail, Adnan
    Patel, Praveen J.
    [J]. OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 361 - 368
  • [7] Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
    Maria Eleftheriadou
    Maria Gemenetzi
    Marko Lukic
    Sobha Sivaprasad
    Philip G. Hykin
    Robin D. Hamilton
    Ranjan Rajendram
    Adnan Tufail
    Praveen J. Patel
    [J]. Ophthalmology and Therapy, 2018, 7 : 361 - 368
  • [8] Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
    Itagaki, Kanako
    Sekiryu, Tetsuju
    Kasai, Akihito
    Sugano, Yukinori
    Ogasawara, Masashi
    Saito, Masaaki
    [J]. BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [9] Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
    Kanako Itagaki
    Tetsuju Sekiryu
    Akihito Kasai
    Yukinori Sugano
    Masashi Ogasawara
    Masaaki Saito
    [J]. BMC Ophthalmology, 20
  • [10] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    [J]. IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
12345